The Florida Pediatric Community Clinical Oncology Program is a consortium of six Florida hospitals and one hospital in Puerto Rico. It is the longest functioning exclusively pediatric CCOP in the US. The CCOP has been continuously funded since 1983 and has the Children's Oncology Group (COG) and the H. Lee Moffitt Cancer Center CCOP Research Base as its research bases. It is among the single largest contributor of patients to treatment and cancer control studies in COG over this 26 year period. The CCOP consistently has outstanding compliance scores and contributes to the administration and science of COG through its members who chair or co-chair research base protocols. The CCOP geographically covers the entire state of Florida and provides pediatric oncology care to the largest population centers in Florida, the fourth largest state in the country: Orlando, Tampa, Ft. Myers, and Hollywood Florida. The CCOP hospital in Puerto Rico services the entire island and the neighboring Caribbean islands and is the major contributor of minority patients to studies. The goal of the Florida Pediatric CCOP is to make available the latest advances in cancer care to patients in Florida and Puerto Rico through participation in clinical trials and to register the majority of their eligible patients on COG protocols, thereby providing quality care in patients'home communities. The Moffitt CCOP Research Base enhances the availability of cancer prevention and control studies. The CCOP provides a unique opportunity to study a geographically-defined population to investigate risk factors, patterns of care, and population-based interventions. The Florida Pediatric CCOP also maintains the CCOP Patient Log which affords the opportunity to ensure the majority of eligible patients are registered on appropriate COG protocols. Over 194 patient registrations are anticipated per year on COG treatment protocols and 38 on protocols approved for cancer control credits per year through the 7 Florida Pediatric CCOP participating centers. COG and Moffitt quality- control procedures apply uniformly to the Florida Pediatric CCOP, ensuring compliance with protocols and external review of pathology, radiotherapy, surgery, and chemotherapy.

Public Health Relevance

The CCOP is the only mechanism for the majority of childhood cancer health care providers and cases in Florida and Puerto Rico to access cooperative group treatment and cancer control studies. It provides access to protocols, investigational drugs, quality assurance review and an opportunity to participate in cutting edge research that is not available otherwise in a community setting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10CA035157-30S1
Application #
8850953
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y (J1))
Program Officer
O'Mara, Ann M
Project Start
1987-07-24
Project End
2014-07-31
Budget Start
2013-06-01
Budget End
2014-07-31
Support Year
30
Fiscal Year
2014
Total Cost
$46,850
Indirect Cost
$1,886
Name
Florida Assn of Pediatric Tumor Prog
Department
Type
DUNS #
022568158
City
Tampa
State
FL
Country
United States
Zip Code
33612
Roy, Hemant K; Turzhitsky, Vladimir; Wali, Ramesh et al. (2015) Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Gut :
Jovanovic, Borko D; Subramanian, Hariharan; Helenowski, Irene B et al. (2015) Clinical Trial Laboratory Data Nested With in Subject: Components of Variance, Sample Size and Cost. Biom Biostat Int J 2:
Lee, Oukseub; Page, Katherine; Ivancic, David et al. (2014) A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast. Clin Cancer Res 20:3672-82
Wong, Stuart J; Campbell, Bruce; Massey, Becky et al. (2013) A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncol 49:970-6
Khan, Seema A; Chatterton, Robert T; Michel, Nancy et al. (2012) Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev Res (Phila) 5:309-19
Marshall, James R; Ip, Clement; Romano, Karen et al. (2011) Methyl selenocysteine: single-dose pharmacokinetics in men. Cancer Prev Res (Phila) 4:1938-44
Xu, Li; Wang, Sophia S; Healey, Megan A et al. (2011) The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research. Cancer Prev Res (Phila) 4:616-21
Pavese, Janet M; Farmer, Rebecca L; Bergan, Raymond C (2010) Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 29:465-82
Grundy, P; Wilson, B; Telzerow, P et al. (1994) Uniparental disomy occurs infrequently in Wilms tumor patients. Am J Hum Genet 54:282-9
Montalvo, F W; Casanova, R; Clavell, L A (1990) Treatment outcome in children with malignancies associated with human immunodeficiency virus infection. J Pediatr 116:735-8

Showing the most recent 10 out of 11 publications